The effectiveness of TDF versus ETV on incidence of HCC in CHB patients: a meta analysis

BACKGROUND: It has been proved that nucleos(t) ide analogues (NAs) therapy could improve underlying liver disease and reduce the incidence of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). However, the difference of effectiveness in reducing HCC occurrence between tenofovir (TDF) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zeyu, Zhou, Yufan, Yang, Jiajin, Hu, Kuan, Huang, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542001/
https://www.ncbi.nlm.nih.gov/pubmed/31142283
http://dx.doi.org/10.1186/s12885-019-5735-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542001/
https://www.ncbi.nlm.nih.gov/pubmed/31142283
http://dx.doi.org/10.1186/s12885-019-5735-9

Ejemplares similares